Recent Entries

• Science: Blocking fibrin holds promise for the treatment of per

  by Samantha James April 15, 2022
  In a new study, researchers from the National Institute of Dental Craniofacial Research (NIDCR) have found that blocking the function of a coagulation protein prevents bone loss caused by periodontal (gingival) disease in mice. According to animal and human data, they found that the accumulation of ...

• Broad Application Areas of Cellulase Release Strong Market Dema

  by Samantha James April 14, 2022
  Cellulase (β-1,4-glucan-4-glucanohydrolase) is a general term for a group of enzymes that degrade cellulose to produce glucose. Cellulase is a kind of complex enzyme, including C1 enzyme, CX enzyme and glucosidase and other components. Among them, C1 enzyme and CX enzyme can decompose cellulose...

• Firstly Uncovered Genetic Clues to Schizophrenia

  by Samantha James March 31, 2022
  Cornel University researchers recently made a breakthrough in the study on schizophrenia with human-derived cerebral organoids.   Schizophrenia is a chronic brain disorder of hitherto unknown etiology, with typical symptoms usually appearing in early adulthood and affecting approximately 1% o...

• In Silico Techniques Are Boosting Drug Discovery

  by Samantha James March 30, 2022
  The phrase "in silico" is pseudo-Latin referring to silicon in computer chips and it has become a frequently used term describing biological or other experiments performed by computers. This is an evolution of traditional in vivo and in vitro models that were used to develop new ...

• A "bad" bacteria in colon cancer may serve a "positive" role in

  by Samantha James March 25, 2022
  Immunotherapy has been successfully applied clinically to treat a wide range of hematological and solid metastatic malignancies. The most widely used drugs targeting immune checkpoints, such as programmed cell death protein 1 (PD-1) and its ligand PD-L1, are effective in a subset of cancer pati...
  comments